Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals (Q35685280)

9 August 2017

Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals (English)

1 reference

9 August 2017

sodium stibogluconate

1 reference

1 reference

J Nieto

1

1 reference

9 August 2017

J Alvar

2

1 reference

9 August 2017

A B Mullen

3

1 reference

9 August 2017

K C Carter

4

1 reference

9 August 2017

C Rodríguez

5

1 reference

9 August 2017

M I San Andrés

6

1 reference

9 August 2017

M D San Andrés

7

1 reference

9 August 2017

A J Baillie

8

1 reference

9 August 2017

F González

9

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

47

1 reference

9 August 2017

2781-2787

1 reference

9 August 2017

9

1 reference

A study of the excretion of organic antimonials using a polarographic procedure

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Dextrans for targeted and sustained delivery of therapeutic and imaging agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Complement-mediated acute effects of liposome-encapsulated hemoglobin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

The interaction of liposomes with the complement system

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Lipid formulations of amphotericin B: recent progress and future directions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Renal clearance of pentavalent antimony (sodium stibogluconate)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Toxicity of antimony and its compounds

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Applicability of anodic-stripping voltammetry and graphite furnace atomic-absorption spectrometry to the determination of antimony in biological matrices: a comparative study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Statistical analysis of pharmacokinetic data

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

The effect of a meal of meat on glomerular filtration rate in dogs at normal urine flows

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182616

Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate

7 December 2018

1 reference

12 December 2020

Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis

1 reference

12 December 2020

Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice

1 reference

12 December 2020

Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation

1 reference

12 December 2020

Subacute toxicity of pentavalent antimony compounds in rats

1 reference

12 December 2020

Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody

1 reference

12 December 2020

Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconate

1 reference

12 December 2020

Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog

1 reference

12 December 2020

Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum

1 reference

12 December 2020

Liposome-complement interactions in rat serum: implications for liposome survival studies

1 reference

12 December 2020

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

1 reference

12 December 2020

The distribution of free and non-ionic vesicular sodium stibogluconate in the dog

1 reference

12 December 2020

Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog

1 reference

12 December 2020

Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs

1 reference

12 December 2020

10.1128/AAC.47.9.2781-2787.2003

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference